Federated Hermes Inc. boosted its stake in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 504.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,620,621 shares of the company’s stock after buying an additional 3,022,026 shares during the quarter. Federated Hermes Inc. owned approximately 0.19% of Kenvue worth $77,952,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. bought a new position in Kenvue during the third quarter valued at about $2,944,816,000. FMR LLC grew its position in Kenvue by 572.1% during the third quarter. FMR LLC now owns 89,182,980 shares of the company’s stock valued at $1,790,794,000 after buying an additional 75,913,107 shares during the period. Wellington Management Group LLP grew its position in Kenvue by 576.1% during the third quarter. Wellington Management Group LLP now owns 71,686,830 shares of the company’s stock valued at $1,439,472,000 after buying an additional 61,084,123 shares during the period. Massachusetts Financial Services Co. MA grew its position in Kenvue by 227.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 61,091,189 shares of the company’s stock valued at $1,226,711,000 after buying an additional 42,449,470 shares during the period. Finally, Morgan Stanley grew its position in Kenvue by 4,057.4% during the third quarter. Morgan Stanley now owns 31,162,614 shares of the company’s stock valued at $625,745,000 after buying an additional 30,413,040 shares during the period. Institutional investors own 97.64% of the company’s stock.
Kenvue Price Performance
KVUE stock opened at $19.58 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.78 and a current ratio of 1.12. The company’s 50 day moving average is $19.83 and its 200 day moving average is $20.16. Kenvue Inc. has a 1-year low of $17.82 and a 1-year high of $27.80.
Kenvue Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 28th. Investors of record on Wednesday, February 14th were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 4.09%. The ex-dividend date was Tuesday, February 13th.
Wall Street Analyst Weigh In
Several equities research analysts have commented on KVUE shares. The Goldman Sachs Group started coverage on shares of Kenvue in a report on Friday, March 1st. They set a “neutral” rating and a $20.00 price objective on the stock. William Blair started coverage on shares of Kenvue in a report on Wednesday, April 3rd. They set a “market perform” rating on the stock. Sanford C. Bernstein started coverage on shares of Kenvue in a report on Thursday, April 11th. They set an “underperform” rating and a $18.00 price objective on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a report on Friday, February 9th. Finally, Royal Bank of Canada dropped their price objective on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, February 9th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Kenvue has a consensus rating of “Hold” and a consensus target price of $24.85.
Get Our Latest Stock Report on KVUE
About Kenvue
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Featured Articles
- Five stocks we like better than Kenvue
- How to Use the MarketBeat Excel Dividend Calculator
- Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
- What is the Australian Securities Exchange (ASX)
- Comprehensive PepsiCo Stock Analysis
- Stock Analyst Ratings and Canadian Analyst Ratings
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE – Free Report).
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.